288MO InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
医学
打开标签
肿瘤科
内科学
临床研究阶段
化疗
随机对照试验
作者
Keiichi Fujiwara,Brian M. Slomovitz,Antonio González Martín,Elsa Kalbacher,Andrea Bagaméri,Sharad Ghamande,Lee Jy,Susana Banerjee,Fernando C. Maluf,Domenica Lorusso,Kan Yonemori,Els Van Nieuwenhuysen,Luis Manso,Linn Woelber,Anneke M. Westermann,Allan Covens,Eric T. Whalley,Marita S. Teng,Ibrahima Soumaoro,Ignace Vergote